PP2 Osteoarthritis research society international hand OA task force: Design and conduct on clinical trials on osteoarthritis (OA) of the hand  by unknown
Podium Presentations 
@ 




MORPHOLOGICAL VALIDATION OF DIFFRACTION 
ENHANCED IMAGING FOR ARTICULAR CARTILAGE 
*C Muehleman, **M Aurich, ***L D Chapman, **J Mollenhauer, 
*K E Kuettner, *A Cole, *** Z Zhong 
*Rush Medica/ College, Chicago, /L. USA **Universjty of Jena, 
Germany I/linois Institute of Technology, Chicago, IL. USA 
.... Brookhaven Nationa/ Laboratory, Upton, N. Y. USA 
Aim: To validate a novel x-ray technology, Diffraction Enhanced 
Imaging (DEI), for the imaging of articular cartilage of synovial 
joints in both normal and disease states. 
Methods: Twenty-five human donor cartilages and whole knee 
and ankle joints at various stages of degeneration, including late- 
stage osteoarthritis, were imaged with a novel x-ray technology, 
DEI. Imaging was carried out at the XI5A beam line at the National 
Synchrotron Light Source, Brookhaven National Laboratory. A 
monochromatic (either 18 or 30 keV) x-ray beam was prepared by 
diffracting the polychromatic beam from the synchrotron with two 
matching crystals. This beam passed through the subject as in 
conventional radiography, but then traversed through a third crys- 
tal (analyzer) that lies between the subject and the radiographic 
plate. All specimens were subsequently examined grossly and 
histologically and correlated to their Diffraction Enhanced images 
(DE images). 
Results; We have shown that DE1 is capable of rendering high 
contrast radiographic images of cartilages of both disarticulated 
and intact human knee and ankle joints. Cartilages of disarticu- 
lated joints displaying no gross histological signs of cartilage 
degeneration appeared intact and homogeneous in their DE 
images. Cartilages taken from donor specimens that exhibited 
varying degrees of cartilage degeneration were visualized on radi- 
ographic plates as having contrast heterogeneities that corre- 
sponded in both degree and location to lesions that were identi- 
fied upon gross visual and histological examination. Degenerative 
signs that were visualized on DE images include fibrillation, fis- 
suring and cysts within the cartilage. Furthermore, the cartilage 
and menisci of intact donor knee and ankle joints were visible in 
their DE images and the thickness and integrity of the articular 
surfaces was easily delineated. Conventional radiography of the 
same specimens, taken at the same x-ray energies rendered no 
visibility of the cartilage, as is expected from its soft-tissue 
nature. 
Conclusion: We have shown that DEI provides high-resolution 
radiographic images of articular cartilage of synovial joints that 
are highly correlated with the morphological status of the speci- 
mens. With further optimization, we believe DEI has great diag- 
nostic potential for the arthritic diseases. 
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Objective: A subcommittee was established to update clinical 
trial design for CA of the hand. 
Method: A systematic review of the literature on clinical trials on 
CA of the hand was performed addressing clinical and radiologi- 
cal assessment methods. Expert opinion supplemented the evi- 
dence based reports to modify the study design from a prioir 
OARSI report. 
Results: Heberden's clinical definition was confirmed. The 
American College of Rheumatology classification criteria remain 
the only research based criteria. There are no biochemical or spe- 
cific genetic markers that are helpful in classification of disease or 
defining progression; however, collection of serum for future 
analysis was felt to be important. There is a poor correlation 
between symptoms, signs, and radiographic hange, that needs 
to be clarified by the study design. 
No instrument has been fully validated for use in hand CA. 
However, for trials examining symptoms, a global pain score was 
felt to be best validated and most relevant as a primary outcome 
measure. The instrument used at the time of screening should be 
the same instrument used during the follow-up examinations. 
Several secondary parameters hould be included. A functional 
index is recommended (e.g., Dreiser index, Auscan). Other meas- 
urements may include stiffness, index of painful joints on pres- 
sure, patient's recorded aesthetic damage, etc. The patient glob- 
al question was felt to be less helpful in evaluation. For trials 
examining structure, the radiograph remains the standard. 20 to 
30 joints need to be examined, depending on the radiographic 
grading system selected. Consensus was that each joint should 
be examined for individual radiographic change; progression 
would be graded on these changes. Further comparison of the 
existing radiographic scales is needed to determine the most 
responsive radiographic scale. 
Conclusion: There has been refinement in the design of clinical 
trials for CA of the hand. New trials need to carefully design their 
criteria and to further validate their nstruments. 
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